Dirk J. Lok

7.3k total citations · 1 hit paper
53 papers, 3.3k citations indexed

About

Dirk J. Lok is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Immunology. According to data from OpenAlex, Dirk J. Lok has authored 53 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 7 papers in Immunology. Recurrent topics in Dirk J. Lok's work include Heart Failure Treatment and Management (23 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Cardiovascular Function and Risk Factors (10 papers). Dirk J. Lok is often cited by papers focused on Heart Failure Treatment and Management (23 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Cardiovascular Function and Risk Factors (10 papers). Dirk J. Lok collaborates with scholars based in Netherlands, United States and United Kingdom. Dirk J. Lok's co-authors include Dirk J. van Veldhuisen, Peter van der Meer, Hans L. Hillege, Adriaan A. Voors, Jan van Wijngaarden, Rudolf A. de Boer, Tiny Jaarsma, Piotr Ponikowski, Erik Lipšic and IJsbrand T. Klip and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Dirk J. Lok

53 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron deficiency in chronic heart failure: An international pooled analysis

2013 534 citations IJsbrand T. Klip, Josep Comín‐Colet et al. American Heart Journal profile →

Peers

Dirk J. Lok

CCM

IMMUN

HEMAT

SURGE

Piotr Rozentryt Poland

Lucia Del Vecchio Italy

Antonella Tufano Italy

Simcha Meisel Israel

John D. Groarke United States

Eli I. Lev Israel

Sunil Nadar United Kingdom

Giuseppina Novo Italy

Elliott Levy United States

Andrea Zuckerman United States

Piotr Rozentryt Poland

Dirk J. Lok

1.3k ×0.7

CCM

236 ×0.3

IMMUN

749 ×1.2

HEMAT

241 ×0.5

SURGE

170 ×0.4

Citations per year, relative to Dirk J. Lok Dirk J. Lok (= 1×) peers Piotr Rozentryt

Countries citing papers authored by Dirk J. Lok

Since Specialization

Citations

This map shows the geographic impact of Dirk J. Lok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk J. Lok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk J. Lok more than expected).

Fields of papers citing papers by Dirk J. Lok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk J. Lok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk J. Lok. The network helps show where Dirk J. Lok may publish in the future.

Co-authorship network of co-authors of Dirk J. Lok

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk J. Lok. A scholar is included among the top collaborators of Dirk J. Lok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk J. Lok. Dirk J. Lok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeurissen, Patrick, et al.. (2022). Use of regional transmural agreements to support the right care in the right place for patients with chronic heart failure—a qualitative study. Netherlands Heart Journal. 31(3). 109–116. 2 indexed citations

Shah, Neeraj, Min Qian, Marco R. Di Tullio, et al.. (2019). Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction. European Journal of Clinical Investigation. 49(6). e13092–e13092. 1 indexed citations

Tullio, Marco R. Di, Min Qian, John L.P. Thompson, et al.. (2018). Left Atrial Volume and Cardiovascular Outcomes in Systolic Heart Failure: Effect of Antithrombotic Treatment. ESC Heart Failure. 5(5). 800–808. 23 indexed citations

Isselt, Eléonore F van Dam van, Jan van Wijngaarden, Dirk J. Lok, & Wilco P. Achterberg. (2018). Geriatric rehabilitation in older patients with cardiovascular disease: a feasibility study. European Geriatric Medicine. 9(6). 853–861. 9 indexed citations

Teerlink, John R., Min Qian, Natalie A. Bello, et al.. (2017). Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients. JACC Heart Failure. 5(8). 603–610. 2 indexed citations

Kato, Tomoko S., Marco R. Di Tullio, Min Qian, et al.. (2016). Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure　– Subanalysis of the WARCEF Trial –. Circulation Journal. 80(3). 619–626. 8 indexed citations

Freudenberger, Ronald S., Bin Cheng, Douglas L. Mann, et al.. (2015). The first prognostic model for stroke and death in patients with systolic heart failure. Journal of Cardiology. 68(2). 100–103. 15 indexed citations

Luttik, Marie Louise, Tiny Jaarsma, Peter Paul van Geel, et al.. (2014). Long-Term Follow-Up in Optimally Treated and Stable Heart Failure Patients: Primary Care vs. Heart Failure Clinic. Results of the COACH-2 Study. European Journal of Heart Failure. 16(11). 1241–1248. 52 indexed citations

Pullicino, Patrick M., Min Qian, Ralph L. Sacco, et al.. (2014). Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. Cerebrovascular Diseases. 38(3). 176–181. 24 indexed citations

10.

Klip, IJsbrand T., Josep Comín‐Colet, Adriaan A. Voors, et al.. (2013). Iron deficiency in chronic heart failure: An international pooled analysis. American Heart Journal. 165(4). 575–582.e3. 534 indexed citations breakdown →

11.

Jørstad, H T, Clemens von Birgelen, Marco Alings, et al.. (2011). IMPROVEMENT OF RISK FACTOR CONTROL AFTER AN ACUTE CORONARY SYNDROME BY A NURSE COORDINATED PREVENTION PROGRAM: RESULTS FROM A RANDOMIZED TRIAL. Journal of the American College of Cardiology. 57(14). E549–E549. 1 indexed citations

12.

Boer, Rudolf A. de, Dirk J. Lok, Adriaan A. Voors, et al.. (2010). CLINICAL AND PROGNOSTIC VALUE OF GALECTIN-3, A NOVEL FIBROSIS-ASSOCIATED BIOMARKER. RELATION WITH CLINICAL AND BIOCHEMICAL CORRELATES OF HEART FAILURE.. Journal of the American College of Cardiology. 55(10). A26.E243–A26.E243. 5 indexed citations

13.

Eurlings, Luc W.M., Wouter E.M. Kok, Aggie H.M.M. Balk, et al.. (2010). Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets. Journal of the American College of Cardiology. 56(25). 2090–2100. 140 indexed citations

14.

Boer, Rudolf A. de, Dirk J. Lok, Tiny Jaarsma, et al.. (2010). Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Annals of Medicine. 43(1). 60–68. 473 indexed citations

15.

Rienstra, Michiel, Harry J.G.M. Crijns, Thera P. Links, et al.. (2008). Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation. JAMA. 300(15). 1784–1784. 45 indexed citations

16.

Lok, Dirk J., Dirk J. van Veldhuisen, Jan van Wijngaarden, et al.. (2006). Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure study. Heart. 93(7). 819–825. 104 indexed citations

17.

Lok, Dirk J., et al.. (2005). Heart Failure Programmes in Countries with a Primary Care-Based Health Care System. Are Additional Trials Necessary? Design of the DEAL-HF Study. European Journal of Heart Failure. 7(5). 910–920. 24 indexed citations

18.

Neuhaus, Karl-Ludwig, G. P. Molhoek, Uwe Zeymer, et al.. (1999). Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction. Journal of the American College of Cardiology. 34(4). 966–973. 62 indexed citations

19.

Quéré, Michel, et al.. (1995). Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure. The American Journal of Cardiology. 76(17). 1253–1258. 21 indexed citations

20.

Veldhuisen, Dirk J. van, A. J. Man inʼt Veld, Peter H.J.M. Dunselman, et al.. (1993). Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT). Journal of the American College of Cardiology. 22(6). 1564–1573. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact